One year experience with computer-assisted propofol sedation for colonoscopy

Area of Science:

• Gastroenterology
• Anesthesiology
• Medical Technology

Background:

• Colonoscopy is a vital diagnostic and screening procedure.
• Traditional sedation methods for colonoscopy, such as midazolam and fentanyl, have established safety profiles but can lead to longer recovery times.
• The adoption of new technologies for sedation aims to improve patient experience and procedural efficiency.

Purpose of the Study:

• To evaluate the one-year clinical experience with computer assisted propofol sedation (CAPS) for colonoscopy.
• To assess the safety, efficacy, and efficiency of CAPS in a routine clinical setting.
• To compare outcomes of CAPS with historical data from traditional sedation methods.

Main Methods:

• A prospective study involving 2677 patients undergoing elective outpatient colonoscopy with CAPS.
• Colonoscopies were performed by certified gastroenterologists with a trained nurse.
• Outcomes including procedural success, polyp detection, procedure time, and recovery time were recorded and compared to historical data from 2286 colonoscopies using midazolam and fentanyl.
• Adverse events associated with CAPS were meticulously documented.

Main Results:

• Colonoscopy completion and polyp detection rates with CAPS were comparable to historical controls.
• Patient recovery times were significantly shorter with CAPS (31 minutes) compared to traditional sedation (45.6 minutes; P < 0.001).
• Adverse events were infrequent and mild, including minor desaturation (0.7%) and hypotension (0.8%), with no serious sedation-related complications.

Conclusions:

• Computer assisted propofol sedation (CAPS) is a safe, effective, and efficient method for moderate sedation during colonoscopy in generally healthy patients.
• CAPS demonstrates a significant advantage in reducing patient recovery times.
• The technology is associated with a low incidence of adverse events, with no serious complications reported.